Changchun Haiwai Pharmaceutical Group

Changchun Haiwai Pharmaceutical Group Co., Ltd., formerly known as Changchun Jinlai Pharmaceutical, is a comprehensive pharmaceutical enterprise based in Changchun, China. Founded in 1988 and restructured in 1999, the company integrates the research, development, manufacturing, and sales of both Traditional Chinese Medicine (TCM) and Western chemical drugs. Its extensive product portfolio includes over 300 varieties, with flagship TCM products such as Langchuang Pills for systemic lupus erythematosus and Tongfengding Tablets for gout. The company operates a large-scale, GMP-certified production base capable of manufacturing diverse dosage forms, including tablets, capsules, and injections. Changchun Haiwai is recognized as a high-tech enterprise in Jilin Province and maintains a dedicated department for the development of new and specialized pharmaceutical products.